Modern approaches to rehabilitation of patients with heart failure. Prospects for using the interval hypoxic-hyperoxic training method
https://doi.org/10.23946/2500-0764-2026-11-1-74-81
Abstract
Aim. The purpose of this review is to analyze modern approaches to rehabilitation and evaluate the possibilities and prospects of using the method of interval hypoxic-hyperoxic training (IGTT) in patients with CHF.
Materials and methods. Analysis of scientific publications presented in databases elibrary.ru PubMed was conducted for the period from 2014 to 2024 on keywords such as "hypoxic effects, interval hypoxic training, hypoxic-hyperoxytherapy, re-oxy therapy, pathophysiological mechanisms of hypoxia, cardiorehabilitation." The inclusion criteria were the results of randomized trials, systematic reviews, as well as original articles with a control group.
Results. It has been shown that the IGTT method is a promising direction that has a pathophysiological basis and demonstrates positive results in clinical trials.
Conclusions. Further development and practical integration of this method require large randomized trials to confirm its clinical efficacy and safety.
About the Authors
A. Yu. Sakharchuk
Research Institute for Complex Issues of Cardiovascular Diseases
Russian Federation
Russian Federation
Dr. Alexey Yu. Sakharchuk, MD, cardiology resident
Barbarash Boulevard, 6, Kemerovo, 650002
N. B. Lebedeva
Research Institute for Complex Issues of Cardiovascular Diseases
Russian Federation
Russian Federation
Dr. Nataliya B. Lebedeva, MD, Associate Professor, Leading Researcher, Laboratory of Rehabilitation
Barbarash Boulevard, 6, Kemerovo, 650002
References
1. Sitnikova MY, Lyasnikova EA, Yurchenko AV, Trukshina MA, Libis RA, Kondratenko VY, et al. [Results of Russian Hospital Chronic Heart Failure Registry in Three Subjects of Russian Federation]. Kardiologiia. 2015;55(10):5–13. (In Russ.). https://doi.org/10.18565/cardio.2015.10.5-13
2. Vedin O, Lam CSP, Koh AS, Benson L, Teng THK, Tay WT, et al. Significance of Ischemic Heart Disease in Patients With Heart Failure and Preserved, Midrange, and Reduced Ejection Fraction: A Nationwide Cohort Study. Circ Heart Fail. 2017;10(6):e003875. https://doi.org/10.1161/CIRCHEARTFAILURE.117.003875
3. Dokainish H, Teo K, Zhu J, Roy A, AlHabib KF, ElSayed A, et al. Global mortality variations in patients with heart failure: results from the International Congestive Heart Failure (INTER-CHF) prospective cohort study. Lancet Glob Health. 2017;5(7):e665–e672. https://doi.org/10.1016/S2214-109X(17)30196-1
4. GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1789–1858. https://doi.org/10.1016/S0140-6736(18)32279-7
5. Virani SS, Alonso A, Aparicio HJ, Benjamin EJ, Bittencourt MS, Callaway CW, et al. Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association. Circulation. 2021;143(8):e254-e743. https://doi.org/10.1161/CIR.0000000000000950
6. Popa IP, Haba MȘC, Mărănducă MA, Tănase DM, Șerban DN, Șerban LI, et al. Modern Approaches for the Treatment of Heart Failure: Recent Advances and Future Perspectives. Pharmaceutics. 2022;14(9):1964. https://doi.org/10.3390/pharmaceutics14091964
7. Fomin IV. Chronic heart failure in Russian Federation: what do we know and what to do. Russian Journal of Cardiology. 2016;(8):7–13. (In Russ.). https://doi.org/10.15829/1560-4071-2016-8-7-13
8. Russian Society of Cardiology (RSC). 2020 Clinical practice guidelines for Chronic heart failur. Russian Journal of Cardiology. 2020;25(11):4083. (In Russ.). https://doi.org/10.15829/1560-4071-2020-4083
9. Drapkina OM, Boytsov SA, Omelyanovskiy VV, Kontsevaya AV, Loukianov MM, Ignatieva VI, et al. Socio-economic impact of heart failure in Russia. Russian Journal of Cardiology. 2021;26(6):4490. (In Russ.). https://doi.org/10.15829/1560-4071-2021-4490
10. Gioeva ZM, Bogdanov AR, Zaletova TS, Bogdanova AA. Obesity as a Risk Factor for Chronic Heart Failure: A Review of the Literature. Doctor.Ru. 2017;10(139):21–25. (In Russ.).
11. Pelliccia A, Sharma S, Gati S, Bäck M, Börjesson M, Caselli S, et al. 2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease. Eur Heart J. 2021;42(1):17–96. https://doi.org/10.1093/eurheartj/ehaa605.
12. Packer M, Anker SD, Butler J, Filippatos G, Ferreira JP, Pocock SJ, et al. Empagliflozin in Patients With Heart Failure, Reduced Ejection Fraction, and Volume Overload: EMPEROR-Reduced Trial. J Am Coll Cardiol. 2021;77(11):1381–1392. https://doi.org/10.1016/j.jacc.2021.01.033.
13. You G, Xie J, Tong W, Zhao Sh. The new perspective of cardiac exercise rehabilitation: based on integrative physiology. Front Physiol. 2025;16:1651589. https://doi.org/10.3389/fphys.2025.1651589
14. Halpin SJ, McIvor C, Whyatt G, Adams A, Harvey O, McLean L, et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation. J. Med. Virol. 2021;93(2):1013–1022. https://doi.org/10.1002/jmv.26368.
15. Vladimirskiy VE, Bobylev YuM. Rehabilitation of patients with chronic heart failure: opportunities and unresolved issues. 2021;4:85–103 (In Russ.). https://doi.org/10.17816/pmj38485%103
16. Writing Committee Members; ACC/AHA Joint Committee Members. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. J Card Fail. 2022;28(5):e1–e167. https://doi.org/10.1016/j.cardfail.2022.02.010
17. Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/ American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2022;79(17):e263–e421. https://doi.org/10.1016/j.jacc.2021.12.012
18. Glazachev OS, Kryzhanovskaya SY, Zapara MA, Dudnik EN, Samartseva VG, Susta D. Safety and Efficacy of Intermittent Hypoxia Conditioning as a New Rehabilitation/ Secondary Prevention Strategy for Patients with Cardiovascular Diseases: A Systematic Review and Meta-analysis. Curr Cardiol Rev. 2021;17(6):e051121193317.https://doi.org/10.2174/1573403X17666210514005235
19. Larina VN, Akhmatova FD, Arakelov SE, Mokhov AE, Doronina IM, Denisova NN. [Modern strategies for cardiac rehabilitation after myocardial infarction and percutaneous coronary intervention]. Kardiologiia. 2020;60(3):111–118. (Russ.). https://doi.org/10.18087/cardio.2020.3.n546
20. Zaree A, Dev S, Yaseen Khan I, Arain M, Rasool S, Khalid Rana MA, et al. Cardiac Rehabilitation in the Modern Era: Optimizing Recovery and Reducing Recurrence. Cureus. 2023;15(9):e46006. https://doi.org/10.7759/cureus.46006
21. Glazachev OS, Lyamina NP, Spirina GK. Intermittent hypoxic conditioning: experience and potential in cardiac rehabilitation programs. Russian Journal of Cardiology. 2021;26(5):4426. (In Russ.). https://doi.org/10.15829/1560-4071-2021-4426
22. Athmuri DN, Bhattacharyya J, Bhatnagar N, Shiekh PA. Alleviating hypoxia and oxidative stress for treatment of cardiovascular diseases: a biomaterials perspective. J Mater Chem B. 2024;12(41):10490–10515. https://doi.org/10.1039/d4tb01126k
23. Uzun AB, Iliescu MG, Stanciu LE, Ionescu EV, Ungur RA, Ciortea VM, et al. Effectiveness of Intermittent Hypoxia-Hyperoxia Therapy in Different Pathologies with Possible Metabolic Implications. Metabolites. 2023;13(2):181. https://doi.org/10.3390/metabo13020181
24. Glazachev O, Kopylov P, Susta D, Dudnik E, Zagaynaya E. Adaptations following an intermittent hypoxia-hyperoxia training in coronary artery disease patients: a controlled study. Clin Cardiol. 2017;40(6):370–376. https://doi.org/10.1002/clc.22670
25. Sasidharan R, Schippers JHM, Schmidt RR. Redox and low-oxygen stress: signal integration and interplay. Plant Physiol. 2021;186(1):66– 78. https://doi.org/10.1093/plphys/kiaa081
26. Yang C, Zhong ZF, Wang SP, Vong CT, Yu B, Wang YT. HIF-1: structure, biology and natural modulators. Chin J Nat Med. 2021;19(7):521–527. https://doi.org/10.1016/S1875-5364(21)60051-1
27. Pugh CW, Ratcliffe PJ. New horizons in hypoxia signaling pathways. Exp Cell Res. 2017;356(2):116–121. https://doi.org/10.1016/j.yexcr.2017.03.008
28. Hadanny A, Efrati S. The hyperoxic-hypoxic paradox. Biomolecules. 2020;10(6):958. https://doi.org/10.3390/biom10060958
29. Bestavashvili A, Glazachev O, Bestavashvili A, Suvorov A, Zhang Y, Zhang X et al. Intermittent Hypoxic-Hyperoxic Exposures Effects in Patients with Metabolic Syndrome: Correction of Cardiovascular and Metabolic Profile. Biomedicines. 2022;10(3):566. https://doi.org/10.3390/biomedicines10030566
30. Bayer U, Likar R, Pinter G, Stettner H, Demschar S, Trummer B, et al. Effects of intermittent hypoxia-hyperoxia on mobility and perceived health in geriatric patients performing a multimodal training intervention: a randomized controlled trial. BMC Geriatr. 2019;19(1):167. https://doi.org/10.1186/s12877-019-1184-1
31. Saharchuk AYu, Egle AP, Chereneva LA, Lebedeva NB. Effects of reoxy therapy in patients who have undergone coronary artery bypass surgery. XIII Eurasian Congress of Cardiologists. Abstracts. 2025;65. (In Russ.). https://doi.org/10.38109/ECC_2025
32. Serebrovskaya TV, Xi L. Intermittent hypoxia training as nonpharmacologic therapy for cardiovascular diseases: Practical analysis on methods and equipment. Exp Biol Med (Maywood). 2016;241(15):1708–1723. https://doi.org/10.1177/1535370216657614
33. Tuter DS, Kopylov PY, Syrkin AL, Glazachev OS, Komarov RN, Katkov AI, et al. Intermittent systemic hypoxic–hyperoxic training for myocardial protection in patients undergoing coronary artery bypass surgery: first results from a single-centre, randomised controlled trial. Open Heart. 2018;5:e000891. https://doi.org/10.1136/openhrt-2018-000891
34. Doehner W, Fischer A, Alimi B, Muhar J, Springer J, Altmann C, et al. Intermittent Hypoxic-Hyperoxic Training During Inpatient Rehabilitation Improves Exercise Capacity and Functional Outcome in Patients With Long Covid: Results of a Controlled Clinical Pilot Trial. J Cachexia Sarcopenia Muscle. 2024;15(6):2781–2791. https://doi.org/10.1002/jcsm.13628
35. Oynotkinova OSh, Matskeplishvili ST, Maslennikova OM, Yershov AA. Comprehensive Approaches to the Correction of Cardiovascular Parameters and Mitochondrial Dysfunction in Metabolic Syndrome by the Method of Hypoxic-Hyperoxic Training. Effective Pharmacotherapy. 2024;20(26):14–23. (In Russ.). https://doi.org/10.33978/2307-3586-2024-20-26-14-23
36. Tian M, Du W, Yang S, Liao Q, Guo F, Li S. Application and progress of hyperbaric oxygen therapy in cardiovascular diseases. Med Gas Res. 2025;15(3):427–434. https://doi.org/10.4103/mgr.MEDGASRES-D-24-00107
37. Zagaĭnaia E, Kopylov FIu, Glazachev OS, Dudnik EN, Bykova AA, Tuter DS, et al. Quality of life in patients with stable angina in application of intermittent hypoxic-hyperoxic training. Russian Journal of Cardiology and Cardiovascular Surgery. 2016;9(3):21‑27. (In Russ.). https://doi.org/10.17116/kardio20169321-27
38. Uzun AB, Nedelcu AD, Stanciu LE, Iliescu MG, Tofolean ID. The Impact of Intermittent Hypoxia-Hyperoxia Therapy on Cardiovascular and Respiratory Parameters. Journal ARS Medica Tomitana. 2023;1(29):18–24. https://doi.org/10.2478/arsm-2023-0004
39. Zebrowska A, Nowak-Lis A, Nowak Z, Hall B. Normobaric hypoxia and exercise training effects on cardiac biomarkers, left ventricular function and aerobic performance in patients after myocardial infarction. European Heart Journal. 2023;44(Suppl 2). https://doi.org/10.1093/eurheartj/ehad655.2397.
Review
For citations:
Sakharchuk A.Yu., Lebedeva N.B. Modern approaches to rehabilitation of patients with heart failure. Prospects for using the interval hypoxic-hyperoxic training method. Fundamental and Clinical Medicine. 2026;11(1):74-81. (In Russ.) https://doi.org/10.23946/2500-0764-2026-11-1-74-81
Views:
212
JATS XML
Email this article 